NID2 and cancer: Previously, our glycoproteomic analysis revealed that Remab6 binds to Tn+ glycoproteins in a Colo205 cell line, such as MUC16, CD44, TGFβ2, SLC2A12, NID2, S1PR1, and MUC13; such glycoproteins are associated with cancer progression across cancer types, including gastrointestinal, breast, pancreas, bladder, prostate, and ovarian tissues of tumors origin43.